There is one clinical trial.
Due to COVID 19 (Corona virus disease)pandemic, majority of surgeries, including surgery for cancer patients got delayed across the globe. Surgeries were limited to emergency set up only. At our institute we tried to perform colorectal cancer surgeries through out the pandemic, albeit in less numbers, as we thought cancer in itself is an emergency setting. we are planning to analyse the prospectively managed database of this particular group of patients over a period of last six 6 months and look out at 30 day post operative morbidity and mortality. Besides we will try to analyse the implications of our decision to carry on with cancer surgeries in terms of number of health care workers who got infected while being involved in primary care of these patients.
Description: patients who died within 30 days following their surgeryMeasure: Early post operative mortality Time: 30 days
Description: post operative complications will be graded as per clavien dindo grading systemMeasure: Early Post operative complications Time: 30 days
Description: determine whether any health care worker involved with the care of this cohort of patients got infected with SARS CoV 2.Measure: Incidence of SARS CoV2 infectivity among health care providers providing direct care to involved patients Time: 30 days
Description: Determine whether any patient from the cohort got infected with SARS CoV 2 during their hospital stay or immediately after dischargeMeasure: Rate of hospital acquired SARS CoV 2 infection among operated patients. Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports